Opexa Therapeutics (OPXA) Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS
10/23/2013 10:14:44 AM
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS) announced it will be a key sponsor of the National Multiple Sclerosis Society’s Walk MS series of events being held in the Houston area and Austin, Texas, during October and November.
Help employers find you! Check out all the jobs and post your resume.
comments powered by